PhonlamaiPhoto
Ichor Holdings (ICHR), a supplier of fluid delivery subsystems for semiconductor capital equipment, hit a new 52-week low on May 6, the day after ICHR released its Q1 FY2025 report, which capped off a huge selloff that saw ICHR
Ichor Holdings: Valued At Less Than Book Value Is Not Necessarily A Bargain
Summary
- ICHR was badly affected by the recent tariff turmoil, but with an easing of the tariff dispute, the stock could make it back to before the tariffs.
- The easing of trade tensions overshadowed the latest report, which may cause some to overlook a number of negative developments.
- Quarterly results have improved in recent quarters, but growth has been a challenge for ICHR over the long term.
- ICHR is likely to move higher in the short term, but whether ICHR can sustain it to make ICHR worthy as an investment is in doubt.
Welcome to my author's site. As an avid follower of SeekingAlpha, I take great interest in articles posted as the subject matter is often something that appeals to me. However, I will sometimes encounter an article that I might not agree with. My purpose is to present an alternative view to readers that they may want to take into account. I hope you find my articles interesting and informative.
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.